The bone graft uses proprietary nanocrystalline hydroxyapatite and collagen-based biopolymer to promote bone growth in the posterolateral spine. The implantation occurred in Europe and opened the doors for global distribution.
More Articles on Spine Devices:
AxioMed Spine Receives CE Mark for cervical Disc
TransCorp Spine Names Christopher Welch President & CEO
6 New Spine Device Company Financial Reports
Pioneer Surgical Technology’s nanOss Bioactive Bone Graft Implanted in Posterolateral Spine
Pioneer Surgical Technology announced its nanOss Bioactive bone graft has been successfully implanted into a human.
RCM Tech Trends You Can’t Ignore: Fresh Insights from UC San Diego Health
Recommended Live Webinar on Feb 11, 2026 12:00 PM - 1:00 PM CST